Hyaluronic Acid and Vaginal Distress

Effects of Hyaluronic Acid Oral Supplementation on the Vaginal Epithelium: a Prospective, Randomized, Double-Blind, Placebo Controlled Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00890487

Enrollment

Registered

2009-04-29

Start date

2009-05-31

Completion date

2009-12-31

Last updated

2009-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal Disease

Brief summary

The purpose of this trial is to study the effects of the oral supplementation hyaluronic acid in menopause women with vaginal distress for treatment vaginal distress.

Interventions

OTHERhyaluronic acid pill

pill, 220 mg, once a day, three months

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender

FEMALE

Age

45 Years to 60 Years

Healthy volunteers

Yes

Inclusion criteria

* menopause * vaginal distress * no other therapy

Exclusion criteria

* vaginal infection * Sjogren Syndrome

Design outcomes

Primary

Measure	Time frame
effects of the oral somministration hyaluronic acid in menopause women with vaginal distress	three months

Countries

Italy

Contacts

Primary ContactTindara LT La Galia, PhD student

giusy.lagalia@yahoo.it+393470635155

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026